Verdence Capital Advisors LLC Eli Lilly & CO Transaction History

Verdence Capital Advisors LLC

$1.28 Billion
Q1 2025

A detailed history of Verdence Capital Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 8,582 shares of LLY stock, worth $6.61 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

8,582

Previous 7,171 19.68%

Holding current value

$6.61 Million

Previous $5.54 Million 28.02%

% of portfolio

0.55%

Previous 0.46%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	BUY	$725.72 - $929.72 $1.02 Million - $1.31 Million	1,411 Added 19.68%	8,582 $7.09 Million
Q4 2024 Feb 06, 2025	BUY	$727.2 - $932.06 $12,362 - $15,845	17 Added 0.24%	7,171 $5.54 Million
Q3 2024 Nov 01, 2024	BUY	$772.14 - $960.02 $396,879 - $493,450	514 Added 7.74%	7,154 $6.34 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $5,074 - $6,363	-7 Reduced 0.11%	6,640 $6.01 Million
Q1 2024 Apr 25, 2024	SELL	$592.2 - $792.28 $114,886 - $153,702	-194 Reduced 2.84%	6,647 $5.17 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $223,205 - $263,130	-425 Reduced 5.85%	6,841 $3.99 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $674,219 - $929,514	1,551 Added 27.14%	7,266 $3.9 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $29,462 - $39,394	-84 Reduced 1.45%	5,715 $2.68 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $20,812 - $24,442	67 Added 1.17%	5,799 $1.99 Million
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $9,324 - $10,865	29 Added 0.51%	5,732 $0
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $19,567 - $22,299	66 Added 1.17%	5,703 $1.84 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $246,397 - $289,306	-884 Reduced 13.56%	5,637 $1.83 Million
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $228,822 - $284,368	975 Added 17.58%	6,521 $1.87 Million
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $9,893 - $12,277	-44 Reduced 0.79%	5,546 $1.53 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $19,722 - $24,271	89 Added 1.62%	5,590 $1.29 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $20,943 - $27,090	-116 Reduced 2.07%	5,501 $1.26 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $512,678 - $663,686	-3,120 Reduced 35.71%	5,617 $1.05 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $390,858 - $517,199	-2,996 Reduced 25.53%	8,737 $1.48 Million
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $57,610 - $66,637	-394 Reduced 3.25%	11,733 $1.74 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $888,094 - $1.07 Million	6,510 Added 115.9%	12,127 $1.99 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $615,012 - $761,210	-5,166 Reduced 47.91%	5,617 $779,000
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $264,733 - $327,896	2,476 Added 29.81%	10,783 $1.42 Million
Q3 2019 Mar 06, 2020	BUY	$106.79 - $116.16 $272,741 - $296,672	2,554 Added 44.39%	8,307 $929,000
Q2 2019 Mar 02, 2020	BUY	$110.79 - $129.32 $43,762 - $51,081	395 Added 7.37%	5,753 $637,000
Q1 2019 Mar 02, 2020	BUY	$111.31 - $131.02 $13,913 - $16,377	125 Added 2.39%	5,358 $695,000
Q4 2018 Feb 25, 2020	BUY	$105.9 - $118.64 $847 - $949	8 Added 0.15%	5,233 $606,000
Q3 2018 Feb 25, 2020	BUY	$85.86 - $107.31 $90,839 - $113,533	1,058 Added 25.39%	5,225 $561,000
Q2 2018 Feb 11, 2020	BUY	$75.7 - $86.88 $2,119 - $2,432	28 Added 0.68%	4,167 $356,000
Q1 2018 Jan 30, 2020	BUY	$74.21 - $87.6 $1,038 - $1,226	14 Added 0.34%	4,139 $320,000
Q4 2017 Jan 30, 2020	BUY	$81.94 - $87.89 $338,002 - $362,546	4,125	4,125 $348,000

Others Institutions Holding LLY

# of Institutions

4,394

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $732B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Eli Lilly & CO Transaction History